Pomezia, Italy

Doriano Lamba

This inventor holds 1 USPTO granted patent. Top assignees: Pangenetics B.v., Scoula Internazionale Superiore Di Studi Avanzati. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doriano Lamba. Retrieved from https://idiyas.com/inventor/doriano-lamba-hk7of2ry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Doriano Lamba: Innovator in Antibody Humanization

Introduction

Doriano Lamba is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of biotechnology, particularly in the humanization of antibodies. His work has implications for therapeutic applications, enhancing the efficacy of treatments.

Latest Patents

Lamba holds a patent titled "Method for the humanization of antibodies and humanized antibodies thereby obtained." This patent describes a method for the humanization of the VH and VL variable regions of an animal antibody of known sequence. The humanized animal antibodies produced through this method, particularly anti-NGF and anti-TrkA humanized animal antibodies, are of great interest in medical research.

Career Highlights

Throughout his career, Doriano Lamba has worked with various organizations, including Pangenetics B.V. and Scuola Internazionale Superiore Di Studi Avanzati. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Lamba has collaborated with notable colleagues such as Sonia Covaceuszach and Antonino Cattaneo. These partnerships have enriched his research endeavors and fostered innovation in the field.

Conclusion

Doriano Lamba's work in antibody humanization represents a significant advancement in biotechnology. His contributions continue to influence therapeutic strategies and enhance our understanding of antibody applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…